Literature DB >> 4102451

De-novo brain tumours in renal-transplant recipients.

S A Schneck, I Penn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102451     DOI: 10.1016/s0140-6736(71)91384-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  46 in total

1.  Epstein-Barr virus in malignancies in renal transplant recipients in Japan.

Authors:  Y Hoshida; Y Tomita; M Ohsawa; X Ning; K Aozasa
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 2.  Glioblastoma multiforme: morphology and biology.

Authors:  K Jellinger
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

Review 3.  Post-transplantation malignancies: here today, gone tomorrow?

Authors:  Edward K Geissler
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

4.  Immunosuppression and malignancy.

Authors: 
Journal:  Br Med J       Date:  1972-09-23

5.  Suppression of cellular immunity in vivo by rifampicin.

Authors:  G L Floersheim
Journal:  Experientia       Date:  1973-12

6.  Cancer research: preparing for a long haul.

Authors: 
Journal:  Br Med J       Date:  1972-07-08

7.  Malignant tumors arising de novo in immunosuppressed organ transplant recipients.

Authors:  I Penn; T E Starzl
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

8.  Neuropsychiatric problems in systemic lupus erythematosus.

Authors:  R Bennett; G R Hughes; E G Bywaters; P J Holt
Journal:  Br Med J       Date:  1972-11-11

9.  Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.

Authors:  D P Jewell; S C Truelove
Journal:  Br Med J       Date:  1972-03-18

10.  The cytochemical demonstration of intracellular immunoglobulin. In neoplasms of lymphoreticular tissue.

Authors:  A J Garvin; S S Spicer; P E McKeever
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.